MX392976B - Composiciones que comprenden cepas bacterianas. - Google Patents

Composiciones que comprenden cepas bacterianas.

Info

Publication number
MX392976B
MX392976B MX2020001632A MX2020001632A MX392976B MX 392976 B MX392976 B MX 392976B MX 2020001632 A MX2020001632 A MX 2020001632A MX 2020001632 A MX2020001632 A MX 2020001632A MX 392976 B MX392976 B MX 392976B
Authority
MX
Mexico
Prior art keywords
bacterial strains
compositions including
including bacterial
compositions
disease
Prior art date
Application number
MX2020001632A
Other languages
English (en)
Spanish (es)
Other versions
MX2020001632A (es
Inventor
Helene Savignac
Ian Jeffery
Imke Elisabeth MULDER
Seanin Marie Mccluskey
Original Assignee
4D Pharma Res Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1712857.0A external-priority patent/GB201712857D0/en
Priority claimed from GBGB1800866.4A external-priority patent/GB201800866D0/en
Application filed by 4D Pharma Res Limited filed Critical 4D Pharma Res Limited
Publication of MX2020001632A publication Critical patent/MX2020001632A/es
Publication of MX392976B publication Critical patent/MX392976B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2020001632A 2017-08-10 2018-08-10 Composiciones que comprenden cepas bacterianas. MX392976B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1712857.0A GB201712857D0 (en) 2017-08-10 2017-08-10 Compositions comprising bacterial strains
GBGB1800866.4A GB201800866D0 (en) 2018-01-19 2018-01-19 Compositions comprising bacterial strains
EP18183642 2018-07-16
PCT/EP2018/071831 WO2019030411A1 (en) 2017-08-10 2018-08-10 COMPOSITIONS COMPRISING BACTERIAL STRAINS

Publications (2)

Publication Number Publication Date
MX2020001632A MX2020001632A (es) 2022-06-08
MX392976B true MX392976B (es) 2025-03-24

Family

ID=63524238

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020001632A MX392976B (es) 2017-08-10 2018-08-10 Composiciones que comprenden cepas bacterianas.

Country Status (14)

Country Link
US (1) US20200237834A1 (enExample)
EP (1) EP3664824A1 (enExample)
JP (1) JP2020529431A (enExample)
KR (1) KR20200038970A (enExample)
CN (1) CN111246866A (enExample)
AU (1) AU2018312955A1 (enExample)
BR (1) BR112020002212A2 (enExample)
CA (1) CA3072013A1 (enExample)
IL (1) IL272491A (enExample)
MA (1) MA49982A (enExample)
MX (1) MX392976B (enExample)
SG (1) SG11202001174XA (enExample)
TW (1) TW201919674A (enExample)
WO (1) WO2019030411A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019180051A1 (en) * 2018-03-19 2019-09-26 4D Pharma Research Limited Compositions comprising bacterial strains
TWI731279B (zh) * 2018-11-21 2021-06-21 葡萄王生技股份有限公司 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途
KR102623834B1 (ko) * 2020-07-13 2024-01-12 서울대학교병원 에스트로겐을 포함하는 장내 미생물총 변화를 통한 남성의 대장암 예방 또는 치료용 조성물
EP4405509A4 (en) * 2021-09-20 2025-10-22 Hudson Inst Med Res BIOTHERAPEUTIC ENTEROCOCCUS ISOLATES
CN117903980B (zh) * 2024-01-05 2024-10-18 四川大学 一种海氏肠球菌及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107305D0 (en) * 1991-04-08 1991-05-22 Unilever Plc Probiotic
JPH08259450A (ja) * 1995-03-17 1996-10-08 Nichinichi Seiyaku Kk インターフェロン産生増強剤
DE102010013209A1 (de) * 2010-03-29 2011-09-29 Technische Universität München Diarrhö-Prophylaktikum
EP2876167A1 (en) * 2013-11-21 2015-05-27 Institut Gustave Roussy Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment
GB201520497D0 (en) * 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41013A (fr) * 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes

Also Published As

Publication number Publication date
EP3664824A1 (en) 2020-06-17
SG11202001174XA (en) 2020-03-30
JP2020529431A (ja) 2020-10-08
WO2019030411A1 (en) 2019-02-14
AU2018312955A1 (en) 2020-04-02
US20200237834A1 (en) 2020-07-30
CA3072013A1 (en) 2019-02-14
TW201919674A (zh) 2019-06-01
MA49982A (fr) 2020-06-17
MX2020001632A (es) 2022-06-08
KR20200038970A (ko) 2020-04-14
IL272491A (en) 2020-03-31
CN111246866A (zh) 2020-06-05
BR112020002212A2 (pt) 2020-07-28

Similar Documents

Publication Publication Date Title
CY1124013T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1125136T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1122344T1 (el) Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων
CY1122184T1 (el) Συνθεσεις περιλαμβανουσες βακτηριακα στελεχη
CY1122148T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
CY1121473T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1123381T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
CY1125659T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CY1120373T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CO2021001912A2 (es) Composiciones anti-cd112r y métodos
CY1122867T1 (el) Συνθεσεις που περιλαμβανουν ενα βακτηριακο στελεχος του blautia hydrogenotrophica για χρηση στην θεραπεια ή προληψη διαρροιας ή δυσκοιλιοτητας
MX373290B (es) Composiciones que comprenden cepas bacterianas.
CY1124286T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
PH12019502915A1 (en) Immunogenic compositions
CY1119674T1 (el) Θεραπεια και προληψη της νοσου αλτσχαϊμερ (ad)
AR106769A1 (es) Composiciones que comprenden cepas bacterianas
EA201992649A1 (ru) Композиции, содержащие бактериальные штаммы